Manning & Napier Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-190,346
Closed -$35.6M 299
2021
Q1
$35.6M Buy
190,346
+6,208
+3% +$1.21M 0.3% 94
2020
Q4
$31.1M Sell
184,138
-15,122
-8% -$2.26M 0.29% 99
2020
Q3
$29.5M Buy
199,260
+3,919
+2% +$607K 0.3% 89
2020
Q2
$32.1M Buy
195,341
+17,293
+10% +$2.65M 0.34% 79
2020
Q1
$24.7M Buy
+178,048
New +$24.5M 0.29% 81
2019
Q2
Sell
-207,483
Closed -$26.9M 338
2019
Q1
$26.9M Buy
207,483
+27,825
+15% +$3.38M 0.29% 76
2018
Q4
$20.8M Buy
179,658
+9,045
+5% +$1.01M 0.25% 82
2018
Q3
$18.3M Buy
170,613
+11,450
+7% +$1.14M 0.18% 102
2018
Q2
$13.6M Buy
159,163
+142,366
+848% +$11.7M 0.13% 111
2018
Q1
$1.3M Buy
16,797
+70
+0.4% +$5.63K 0.01% 280
2017
Q4
$1.41M Buy
+16,727
New +$1.42M 0.01% 289

Other funds holding LLY

Manning & Napier Group's LLY Position: Q2 2021 in Review

Manning & Napier Group sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 190,346 shares — an estimated $35.6M sold.

Manning & Napier Group first reported a position in LLY in Q4 2017 and held it in 11 quarters. The position peaked at $35.6M in Q1 2021. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Manning & Napier Group reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
  • Manning & Napier Group sold 190,346 Eli Lilly shares in Q2 2021, an estimated $35.6M.
  • Manning & Napier Group first reported a position in Eli Lilly in Q4 2017 and held it in 11 quarters.
  • Manning & Napier Group's Eli Lilly position peaked at $35.6M in Q1 2021.
  • 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Manning & Napier Group's 13F filing for Q2 2021, filed 19 Jul 2021.